2012
DOI: 10.1016/j.eururo.2012.05.072
|View full text |Cite
|
Sign up to set email alerts
|

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

Abstract: Please visit www.eu-acme.org/ europeanurology to read and answer questions on-line. The EU-ACME credits will then be attributed automatically. AbstractContext: Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal management of clinically localized, early-stage disease remains unknown, and profound quality of life issues surround PCa interventions. Objective: To systematically summarize the current literature on the management of low-risk PCa with active surveillance (AS), with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
387
1
22

Year Published

2014
2014
2020
2020

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 540 publications
(423 citation statements)
references
References 60 publications
13
387
1
22
Order By: Relevance
“…Even with the most stringent selection criteria, some patients with apparently low-risk disease actually harbour unfavourable disease due to inaccuracies in currently used (repeat) biopsy protocols [4,5]. In contrast, current AS criteria may be too strict, thereby excluding some patients in whom expectant management would be appropriate and safe [6].…”
Section: Introductionmentioning
confidence: 99%
“…Even with the most stringent selection criteria, some patients with apparently low-risk disease actually harbour unfavourable disease due to inaccuracies in currently used (repeat) biopsy protocols [4,5]. In contrast, current AS criteria may be too strict, thereby excluding some patients in whom expectant management would be appropriate and safe [6].…”
Section: Introductionmentioning
confidence: 99%
“…The ultimate objective is to delay or avoid the morbidities associated with radical treatments without compromising survival. [8][9][10] Although AS is an established management option for low-risk prostate cancer, different AS protocols have been adopted. [11][12][13][14][15][16][17] The most commonly used include those from the University of Toronto, 11 Royal Marsden, 12 John Hopkins, 13,14 University of California San Francisco (UCSF), 15 Memorial Sloan Kettering Cancer Center (MSKCC), 16 and Prostate Cancer Research International: Active Surveillance (PRIAS).…”
Section: Discussionmentioning
confidence: 99%
“…9 Disease progression is one driving factor for abandoning AS, but anxiety is clearly another factor for why some men elect for treatment. However, there is every reason to believe that this mindset can change.…”
Section: Living With Untreated Cancer Is Not Easymentioning
confidence: 99%